LABORATORY MONITORING OF ORAL ANTICOAGULANT-THERAPY - ARE WE BEING MISLED

被引：4

作者：

ALBERS, GW ^{[1
]}

机构：

[1] STANFORD UNIV, MED CTR, STANFORD, CA 94305 USA

来源：

NEUROLOGY | 1993年 / 43卷 / 03期

关键词：

D O I：

10.1212/WNL.43.3_Part_1.468

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：468 / 470

页数：3

共 21 条

[1] STROKE PREVENTION IN NONVALVULAR ATRIAL-FIBRILLATION - A REVIEW OF PROSPECTIVE RANDOMIZED TRIALS [J].

ALBERS, GW ;

SHERMAN, DG ;

GRESS, DR ;

PAULSETH, JE ;

PETERSEN, P .

ANNALS OF NEUROLOGY, 1991, 30 (04) :511-518

[2]

ALTMAN R, 1991, J THORAC CARDIOV SUR, V101, P427

[3] RELIANCE ON PROTHROMBIN TIME RATIOS CAUSES SIGNIFICANT ERRORS IN ANTICOAGULATION THERAPY [J].

BUSSEY, HI ;

FORCE, RW ;

BIANCO, TM ;

LEONARD, AD .

ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (02) :278-282

[4] DIAGNOSIS AND TREATMENT OF ISCHEMIC STROKE [J].

CAPLAN, LR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (17) :2413-2418

[5] CANADIAN ATRIAL-FIBRILLATION ANTICOAGULATION (CAFA) STUDY [J].

CONNOLLY, SJ ;

LAUPACIS, A ;

GENT, M ;

ROBERTS, RS ;

CAIRNS, JA ;

JOYNER, C .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :349-355

[6] SUBSTANDARD MONITORING OF WARFARIN IN NORTH-AMERICA - TIME FOR CHANGE [J].

HIRSH, J .

ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (02) :257-258

[7]

HIRSH J, 1991, NEW ENGL J MED, V324, P1865

[8] ORAL ANTICOAGULANTS - MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE [J].

HIRSH, J ;

DALEN, JE ;

DEYKIN, D ;

POLLER, L .

CHEST, 1992, 102 (04) :S312-S326

[9] OPTIMAL THERAPEUTIC RANGE FOR ORAL ANTICOAGULANTS [J].

HIRSH, J ;

POLLER, L ;

DEYKIN, D ;

LEVINE, M ;

DALEN, JE .

CHEST, 1989, 95 (02) :S5-S11

[10]

HIRSH J, 1988, THROMB HAEMOSTASIS, V59, P129

← 1 2 3 →